Jaundice Flashcards
Definition
Jaundice is the visible manifestation of increased levels of
bilirubin in the body.
– It is not a disease, but only a symptom
Values
*Normal BR =0,1 - 1mg/dl (2-17μmol/l)
(max 1,3-1,5mg/dl)
*Conjugated BRD =0-0,3mg/dl (0-5 μmol/l)
*In adults sclera appears jaundiced when serum bilirubin exceeds
BR>2mg/dl (5-7mg/dl in neonates)
Bilirubin
End product of hemoglobin metabolism that is excreted in
bile.
1g Hb ⇒ 34mg BR
In neonates -75% : from catabolism of circulating RBCs
-25% :*from ineffective erythropoiesis
BR has no known physiologic function
The non-conjugated form has the potential CNS
toxicity due to fat soluble properties and
hematoencephalic barrier permeability during the
neonatal period
- Unconjugated BR (indirect)
– Non-polar, toxic, water insoluble compound, MW 584
– Permeates easily through lipid-containing barriers (blood-brain
barrier – important risk of neurotoxicity – kernicterus)
– Requires conjugation with glucuronic acid to form a water soluble
product that can be excreted
- It will circulate to the liver reversibly bound to albumin (MW 70,000)
- Conjugated (direct) bilirubin - polar, high MW, water-soluble
compound
Conjugation
- Conjugated bilirubin crosses the placenta very little and conjugation
is not active in the fetus (low levels of UDPGT - about 1% of the
adult levels at 30 - 40 weeks gestation) - After birth, the levels of UDPGT rise rapidly but do not reach the
adult levels until 4-6 weeks of age. - Ligandins, which are necessary for intracellular transport of bilirubin,
are also low at birth and reach adult levels by 3-5 days.
Enterohepatic circulation
- Conjugated bilirubin is unstable and easily hydrolyzed to
unconjugated bilirubin. - This process occurs non-enzymatically in the duodenum and
jejunum
!!! It occurs also in the presence of beta-glucuronidase, an enteric
mucosal enzyme having high levels:
- in newborn infants
- in human milk.
Hyperbilirubinemia
Hyperbilirubinemia
-Direct (Conjugated)
-Indirect (Un-conjugated)
Conjugated Hyperbilirubinemia is present,
* >10 -25% of total bilirubin is conjugated
* >2mg/dl is conjugated
If neither criteria is met, hyperbilirubinemia is classified
as un-conjugated.
Kernicterus
- “nuclear jaundice“, german term, with kern = grain,
core, indicating the most commonly afflicted region
of the brain (ie, the nuclear region).
Kernicterus or bilirubin encephalopathy
neurologic syndrome resulting from deposition of unconjugated (
indirect) bilirubin in the basal ganglia and brainstem nuclei
Pathogenesis is multifactorial Unconjugated bilirubin levels
- Albumin binding and unbound bilirubin levels
- Passage across the blood brain barrier
- Neuronal susceptibility to injury
- Disruption of the blood – brain barrier by : disease, asphyxia, acidoza…
Kernicterus factors favoring
– increased BR production,
– acidosis (sepsis), hypoproteinemia,
– the presence of substances that compete with the binding of
albumin BR (metabolites, drugs),
– altered hepatic metabolism of BR,
– increasing BR enterohepatic recirculation
- Important factors in the appearance of kernicterus :
– the BR (unconjugated, free) level,
– the day of exposure (day3)
Uncojugated BR induced CNS damage (basal ganglia)
- Clinical signs - days 2-10
– Severe depression: lethargy, decreased / disappearance of archaic
reflexes (sucking, Moro)
– Excitation: opistotonus, seizures, screaming, bulging AF
– Death/neurological sequelae: impaired hearing, vision, cerebral
palsy, seizures, memory loss, behavioral disorders
Causes of Kernicterus
1.Massive haemolysis
2.Criegler Najjar disease ( tip I Arias),
3.Prematurity
Clinical Findings
Acute
Lethargy
Poor feeding
Tone abnormalities
Opisthotonus
High pitched cry
Seizures
Apnea
Abnormal auditory brainstem response
Chronic
Mild neurodevelopmental delays
Choreoathetoid cerebral palsy
Paralysis of upward gaze
Sensorineural hearing loss
Dental dysplasia
KERNICTERUS – PREVENTION
Universal screening for hyperbilirubinemia in the first 24 -48 hr of life
to detect infants at high risk for severe jaundice and bilirubin –
induced neurologic dysfunction
Any infant who is jaundiced before 24 hr requires measurement of
the serum bilirubin level and if it is elevated - infant should be
evaluated for possible hemolytic disease
Follow –up should be provided within 2 – 3 days of discharge to all
neonates discharged earlier than 48 hr after birth
Early follow –up is particularly important for infants younger than 38
weeks gestation
Increased bilirubin production
– Daily 6-10mg/kg/day BR (3-4mg/kg/day adult)
– Larger circulating red blood cell volume
– Shortened RBC lifespan (70-90 days vs 120 days in adult)
– Substantial production from other sources
Lower plasmatic transport
In newborn the albumin affinity for bilirubin is low
Limited hepatic capacity of bilirubin metabolism
– Defective uptake from plasma into liver cell (deficiency of
LIGANDIN)
– Defective conjugation (UDP-glucuronosyl transferase: <1% of adult
activity during the first 10 days of life)
– Decreased excretion
Increased entero-hepatic circulation
– 6 times higher than in the adult
– Higher in intestinal obstructions, decreased intestinal motility,
fasting
INCREASED PRODUCTION OF BILIRUBINE
Increased erythrocyte turnover
- NORMAL - Shortened RBC lifespan
- PATOLOGIC - HEMOLYSIS - blood group incompatibilities
(ABO/Rh), enzyme deficiencies (G6PD, piruvatkinaza),
structural anomalies(sferocytosis…)
Blood sequestered (hemoragies)
- Hematoma /cephalhematoma, hemangiomas